Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New drug candidates for bipolar disorder—A nation‐wide population‐based study
Lars Vedel Kessing, Helene C. W. Rytgaard, Thomas Alexander Gerds, et al.
Bipolar Disorders (2019) Vol. 21, Iss. 5, pp. 410-418
Open Access | Times Cited: 25

Showing 25 citing articles:

Accelerated aging in bipolar disorder: A comprehensive review of molecular findings and their clinical implications
Gabriel R. Fries, Madeline J. Zamzow, Taylor Andrews, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 112, pp. 107-116
Closed Access | Times Cited: 85
Bipolar disorder: An evolutionary psychoneuroimmunological approach
Markus J. Rantala, Severi Luoto, Javier I. Borráz-León, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 122, pp. 28-37
Closed Access | Times Cited: 76
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice
Paolo Fusar‐Poli, Mirko Manchia, Nikolaos Koutsouleris, et al.
European Neuropsychopharmacology (2022) Vol. 63, pp. 17-34
Open Access | Times Cited: 65
Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
Francesco Bartoli, Daniele Cavaleri, Bianca Bachi, et al.
Journal of Psychiatric Research (2021) Vol. 143, pp. 230-238
Closed Access | Times Cited: 30
Statins: Neurobiological underpinnings and mechanisms in mood disorders
Adam J. Walker, Yesul Kim, Igor Borissiouk, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 693-708
Closed Access | Times Cited: 25
The drug discovery drought in bipolar disorder: barriers and solutions
Jee Hyun Kim, Ken Walder, Bruna Panizzutti, et al.
Biological Psychiatry (2025)
Closed Access
A Survey Exploring People's Experiences With Lithium Bought as a Supplement: Une enquête sur l’expérience des personnes avec le lithium en supplément
Rebecca Strawbridge, Samuel Myrtle, Pietro Carmellini, et al.
The Canadian Journal of Psychiatry (2025)
Closed Access
Association of lipid-modifying medication with reduced mortality in bipolar disorder: A nationwide cohort study
Pao‐Huan Chen, Shang‐Ying Tsai, Po‐Yu Chen, et al.
Journal of Affective Disorders (2025)
Closed Access
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Yoo Jin Jung, David Tweedie, Michael T. Scerba, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 23
Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes
Lucy Colbourne, Sierra Luciano, Paul J. Harrison
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients
Richard Shaw, Daniel Mackay, Jill P. Pell, et al.
Psychological Medicine (2020) Vol. 51, Iss. 7, pp. 1183-1191
Open Access | Times Cited: 21
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action
Mirko Manchia, Eduard Vieta, Olav B. Smeland, et al.
European Neuropsychopharmacology (2020) Vol. 36, pp. 121-136
Open Access | Times Cited: 20
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
Maria Carolina Bittencourt Gonçalves, Roberta Andrejew, Carolina Gubert
CNS Drugs (2022) Vol. 36, Iss. 8, pp. 787-801
Open Access | Times Cited: 11
Acetylsalicylic Acid and Mood Disorders: A Systematic Review
Monika Dominiak, Adam Gędek, Michalina Sikorska, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 67-67
Open Access | Times Cited: 8
Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with Schizophrenia and Bipolar Disorder
Gerardo Mendez Victoriano, Yunting Zhu, Frank A. Middleton, et al.
Psychiatry Research (2024) Vol. 340, pp. 116141-116141
Open Access | Times Cited: 1
Effects of low-dose aspirin in bipolar disorder: study protocol for a randomised controlled trial (the A-Bipolar RCT)
Caroline Fussing Bruun, Jeff Zarp, Julie Lyng Forman, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e084105-e084105
Open Access | Times Cited: 1
Acetylsalicylic acid and its metabolite gentisic acid may act as adjunctive agents in the treatment of psychiatric disorders
Meric A. Altinöz, Aysel Özpınar
Behavioural Pharmacology (2019) Vol. 30, Iss. 8, pp. 626-640
Closed Access | Times Cited: 9
THERAPEUTIC TARGETING OF BRAIN ARACHIDONIC ACID CASCADE IN BIPOLAR DISORDER BY LOW DOSE ASPIRIN AND CELECOXIB
Stanley I. Rapoport, Joseph R. Hibbeln
Prostaglandins Leukotrienes and Essential Fatty Acids (2020) Vol. 159, pp. 102118-102118
Closed Access | Times Cited: 9
Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats
Rachel Shvartsur, Galila Agam, Shnaider Alla, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1827-1827
Open Access | Times Cited: 8
Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder – A nationwide cohort study
Jonne Lintunen, Markku Lähteenvuo, Antti Tanskanen, et al.
Journal of Affective Disorders (2022) Vol. 313, pp. 43-48
Open Access | Times Cited: 5
Differential levels of inflammatory and neuroendocrine markers in the hippocampus and anterior cingulate cortex of bipolar disorder subjects: A post-mortem study
Camila Nascimento, Paula Villela Nunes, Cláudia Kimie Suemoto, et al.
Brain Behavior and Immunity (2020) Vol. 90, pp. 286-293
Open Access | Times Cited: 7
Aspirin and celecoxib may help to rectify a neurotransmission imbalance in bipolar disorder
Stanley I. Rapoport
Medical Hypotheses (2021) Vol. 149, pp. 110536-110536
Open Access | Times Cited: 6
Protective Effect of Lipid-Modifying Medication on Natural and Suicide Mortality in Bipolar Disorder
Pao‐Huan Chen, Shang‐Ying Tsai, Po‐Yu Chen, et al.
(2024)
Closed Access
The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients
Richard Shaw, Daniel Mackay, Jill P. Pell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Early Signal Detection: Data Mining of Mental Disorders with Statins
María-Isabel Jiménez-Serranía
IntechOpen eBooks (2022)
Open Access
Page 1

Scroll to top